Tumor budding in upper gastrointestinal carcinomas
The basis of personalized medicine in oncology is the prediction of an individual’s risk of relapse and death from disease. The presence of tumor budding (TB) at the tumor-host interface of gastrointestinal cancers has been recognized as a hallmark of unfavorable disease biology. TB is defined as th...
Main Authors: | Viktor Hendrik Koelzer, Rupert eLanger, Inti eZlobec, Alessandro eLugli |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2014-08-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fonc.2014.00216/full |
Similar Items
-
Stratification and prognostic relevance of Jass’s molecular classification of colorectal cancer
by: Inti eZlobec, et al.
Published: (2012-02-01) -
Loss of Cdx2 expression in primary tumors and lymph node metastases is specific for mismatch repair-deficiency in colorectal cancer
by: Heather eDawson, et al.
Published: (2013-10-01) -
Molecular and pathogenetic aspects of tumor budding in colorectal cancer
by: Heather eDawson, et al.
Published: (2015-03-01) -
Epstein-Barr virus in gastro-esophageal adenocarcinomas – single center experiences in the context of current literature.
by: Vera eGenitsch, et al.
Published: (2015-03-01) -
Prognostic and predictive significance of circulating biomarkers in patients with advanced upper gastrointestinal cancer undergoing systemic chemotherapy
by: Ningning Li, et al.
Published: (2023-06-01)